This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_SKIN_SCALPNECK_EXALLC for full statistics.
Carcinoma in situ of skin of scalp and neck
CD2_INSITU_SKIN_SCALPNECK
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
739 |
4. Check minimum number of eventsNone |
739 |
5. Include endpointsNone |
739 |
6. Filter based on genotype QC (FinnGen only) |
739 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis verticis cranii
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of scalp and neck
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of scalp and neck
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 739 | 205 | 534 |
| Unadjusted period prevalence (%) | 0.19 | 0.07 | 0.24 |
| Median age at first event (years) | 78.01 | 77.79 | 78.10 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 629
- Matched controls
- 6291
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
4503599627370496.0
323.0
626
*
L57.0
ICD-10 Finland
Actinic keratosis
50.8
323.0
527
580
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
21.1
222.8
379
421
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
41.2
180.9
229
86
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
15.1
173.4
335
442
TQW99
NOMESCO Finland
Other minor procedure on skin
21.2
163.3
257
198
ZXC50
NOMESCO Finland
Cryotherapy
19.9
118.7
187
131
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
31.9
111.9
150
61
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
12.7
109.1
212
241
R23.8
ICD-10 Finland
Other and unspecified skin changes
8.0
107.5
299
637
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
18.9
106.3
170
121
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
18.1
104.0
169
125
D06BB10
ATC
imiquimod; topical
16.0
103.2
177
150
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
8.7
88.4
216
357
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
19.3
78.7
123
78
ZXC15
NOMESCO Finland
Use of photodynamic technique
25.2
77.8
111
53
ZXC20
NOMESCO Finland
Use of chemical agents
19.5
77.6
121
76
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
75.3
75.6
85
13
S18
ICPC
Laceration/cut
4.5
67.2
433
2076
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
10.1
61.2
129
156
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.4
58.1
151
256
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
16.3
56.9
94
67
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
24.6
56.1
80
37
ZQZ00
NOMESCO Finland
Treatment of several skin areas
39.9
54.1
68
19
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
32.1
52.2
69
24
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
17.0
48.2
78
52
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
5.5
44.8
147
329
ZZR00
NOMESCO Finland
Flap of skin
12.1
43.7
82
77
Z2221
NOMESCO Finland
Medical doctor
3.5
43.4
269
1096
XQ848
NOMESCO Finland
Dermatological photography
10.2
40.1
82
91
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
31.3
39.3
52
18
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
9.6
36.0
76
89
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
59.2
33.6
39
7
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
32.6
317
1669
A98
ICPC
Health maint/preventive medicine
5.4
32.2
595
4799
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
8.9
32.0
70
87
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
13.0
30.8
55
46
L82
ICD-10 Finland
Seborrhoeic keratosis
3.4
30.8
179
662
R4110
NOMESCO Finland
Physiotherapy
2.9
30.1
237
1078
ZXE00
NOMESCO Finland
One hour or less
2.6
29.1
312
1703
SPAT1153
SPAT
Removal of sutures
2.6
28.8
303
1635
127
Kela drug reimbursment
Transplant complication
21.8
28.2
41
20
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
23.6
28.2
40
18
WX110
NOMESCO Finland
Local anesthesy
2.6
27.7
424
2792
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
8.1
27.4
63
85
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
21.7
25.5
37
18
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
25.4
312
1790
S21
ICPC
Skin texture symptom/complaint
3.4
25.3
141
495
Z3231
NOMESCO Finland
Registered nurse
2.6
25.1
251
1283
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
10.9
24.5
47
46
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
20.0
24.2
36
19
WX002
NOMESCO Finland
Sedation and analgesia
2.8
24.1
187
819
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
15.9
24.1
39
26
E0000UV
ATC
NA
2.4
22.7
282
1597
S29
ICPC
Skin symptom/complaint other
2.9
22.3
159
658
J01DB01
ATC
cefalexin; oral
2.6
21.6
516
3992
TQW80
NOMESCO Finland
Local dermatologic skincare
7.6
21.5
51
72
Z94.0
ICD-10 Finland
Kidney transplant status
24.1
21.4
30
13
Z3226
NOMESCO Finland
Physiotherapist
2.8
21.2
164
710
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
62.2
21.0
24
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
62.2
21.0
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
20.9
213
1078
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
5.7
20.7
61
116
L04AD01
ATC
ciclosporin; systemic
11.5
20.4
38
35
L04AA06
ATC
mycophenolic acid; systemic
15.1
20.1
33
23
D06BX02
ATC
ingenol mebutate; topical
7.9
20.0
46
62
DAB00
NOMESCO Finland
Excision of lesion of auricle
10.9
19.9
38
37
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
30.0
19.8
26
9
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
18.5
19.7
30
17
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
15.3
19.6
32
22
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.9
19.2
65
145
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
4.5
19.2
70
169
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
8.7
19.0
41
50
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
8.4
18.6
41
52
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
14.2
17.9
30
22
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.0
17.8
74
202
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
68.6
17.8
20
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
15.1
17.8
29
20
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.2
17.3
42
62
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
17.0
359
2464
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
16.6
182
938
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
20.7
16.5
24
12
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
15.8
137
624
XQ845
NOMESCO Finland
Dermatoscopy
7.1
15.2
37
55
Z71.8
ICD-10 Finland
Other specified counselling
2.3
14.9
152
751
ZZA00
NOMESCO Finland
Split skin graft
4.6
14.8
52
121
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
14.9
14.1
23
16
N02BE01
ATC
paracetamol; systemic, rectal
2.4
14.1
546
4618
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
13.7
66
204
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
8.6
13.6
29
35
A11CC03
ATC
alfacalcidol; systemic
6.4
13.5
35
57
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
11.8
13.4
24
21
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
14.2
13.3
22
16
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
4.7
13.1
44
98
A12AA04
ATC
calcium carbonate; oral
7.9
13.0
29
38
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.7
12.9
44
100
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
12.7
163
887
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
15.8
12.7
20
13
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
5.8
12.6
35
63
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
9.9
12.3
24
25
B07.9
ICD-10 Finland
Verruca simplex
5.5
12.3
36
69
J01CA04
ATC
amoxicillin; systemic
1.9
12.3
460
3684
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
12.1
134
681
DHB00
NOMESCO Finland
Excision of lesion of external nose
8.9
12.1
25
29
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
18.5
12.1
18
10
ZXA00
NOMESCO Finland
Right side
1.9
11.7
217
1356
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.4
11.5
34
66
DAB10
NOMESCO Finland
Partial excision of auricle
12.1
11.4
20
17
ZZA50
NOMESCO Finland
Full thickness skin graft
12.1
11.4
20
17
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
11.2
49
141
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
11.1
148
813
D07AB08
ATC
desonide; topical
2.6
11.1
85
358
M79.6
ICD-10 Finland
Pain in limb
1.9
11.0
223
1436
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.1
10.8
42
109
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
10.6
110
541
ZXD05
NOMESCO Finland
Urgent procedure
1.9
10.6
217
1393
TQW40
SPAT
NA
4.9
10.6
34
73
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
9.4
10.6
21
23
C08CA01
ATC
amlodipine; oral
1.8
10.4
299
2143
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.8
10.3
20
21
L04AA01
ATC
[U] ciclosporin; systemic
6.1
10.2
27
46
L04AX01
ATC
azathioprine; systemic
4.1
10.1
38
96
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.6
10.1
34
77
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
40.7
10.0
12
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.4
9.9
35
83
137
Kela drug reimbursment
Uraemia requiring dialysis
12.4
9.9
17
14
Z49.0
ICD-10 Finland
Preparatory care for dialysis
10.9
9.8
18
17
TK800
NOMESCO Finland
Hemodialysis
5.5
9.8
28
53
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
13.6
9.7
16
12
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.0
9.7
21
27
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
6.5
9.6
24
38
QAE99
SPAT
NA
15.3
9.5
15
10
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
9.5
276
1969
S77
ICPC
Malignant neoplasm of skin
5.5
9.5
27
51
C44.49
ICD-10 Finland
Malignant tumor of the skin of the scalp and of the neck other or unspecified histology
30.5
9.4
12
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
30.5
9.4
12
*
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
12.6
9.4
16
13
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
9.2
156
933
205
Kela drug reimbursment
Chronic hypertension
1.7
9.2
266
1889
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
11.7
9.1
16
14
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
9.0
57
215
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
24.4
8.9
12
5
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
8.9
176
1108
M79.1
ICD-10 Finland
Myalgia
2.4
8.8
74
326
D06BX01
ATC
metronidazole; topical
2.6
8.6
64
264
L85.80
ICD-10 Finland
Hudhorn
10.2
8.6
16
16
D07AC01
ATC
betamethasone; topical
1.7
8.5
224
1535
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
27.9
8.5
11
*
ZXC10
NOMESCO Finland
Use of laser
5.0
8.5
26
54
D04
ICD-10 Finland
Carcinoma in situ of skin
+∞
8.3
8
*
UJF32
NOMESCO Finland
Coloscopy
1.7
8.2
193
1279
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
17.4
8.1
12
7
ZXA05
NOMESCO Finland
Left side
1.7
8.1
189
1247
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
8.0
115
643
S15
ICPC
Foreign body in skin
2.7
8.0
54
211
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
8.0
74
344
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
7.9
164
1042
ZY010
NOMESCO Finland
Hospital outpatient
4.1
7.9
29
73
XW000
NOMESCO Finland
Bone marrow biopsy
2.9
7.8
46
166
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
45.5
7.7
9
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
7.7
73
344
B01AB10
ATC
tinzaparin; parenteral
2.5
7.7
60
257
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
7.6
213
1475
D07XC01
ATC
betamethasone, combinations; topical
2.0
7.6
95
504
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
7.2
7.5
17
24
ZXA10
NOMESCO Finland
Bilateral
1.8
7.5
147
917
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.5
199
1360
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.7
7.4
48
185
Z49.2
ICD-10 Finland
Other dialysis
11.0
7.3
13
12
S82
ICPC
Naevus/mole
2.1
7.3
83
423
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.4
7.2
16
22
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
7.2
122
726
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
20.3
7.1
10
5
Z2446
NOMESCO Finland
Social worker
2.8
7.1
45
171
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
7.0
251
1850
C09CA01
ATC
losartan; oral
1.7
7.0
177
1189
WX320
NOMESCO Finland
Spinalanesthesy
1.7
6.9
158
1029
ZXD20
NOMESCO Finland
Day surgery
2.1
6.9
84
438
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
6.9
134
830
C44
ICD-10 Finland
Other malignant neoplasms of skin
14.0
6.9
11
8
R4120
NOMESCO Finland
Occupational therapy
2.8
6.9
44
167
R60.0
ICD-10 Finland
Localized oedema
2.0
6.9
92
501
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
8.4
6.9
14
17
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
6.8
64
299
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
11.1
6.8
12
11
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
6.2
6.8
17
28
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
16.9
6.8
10
6
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
16.9
6.8
10
6
Z02.4
ICD-10 Finland
Examination for driving licence
1.6
6.7
220
1578
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
6.7
41
153
SPAT1325
SPAT
Vaccination
1.6
6.7
263
1976
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
6.0
6.6
17
29
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
6.0
6.6
17
29
WX402
NOMESCO Finland
General anaesthesia
2.0
6.6
88
478
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.4
6.6
22
51
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.6
326
2585
D02AE01
ATC
carbamide; topical
2.5
6.6
47
193
B05DA
ATC
Isotonic solutions
10.2
6.6
12
12
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
6.5
69
342
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
3.3
6.5
30
93
3AC01
NOMESCO Finland
NA
6.6
6.4
15
23
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
6.4
201
1425
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
6.3
260
1966
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.4
6.3
29
656
Z94.4
ICD-10 Finland
Liver transplant status
26.9
6.2
8
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.6
6.2
20
45
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
6.2
158
1058
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
6.2
247
1856
X57
ICD-10 Finland
Unspecified privation
4.3
6.2
21
50
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.0
6.2
35
123
L17
ICPC
Foot/toe symptom/complaint
1.7
6.1
158
1062
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
6.1
57
265
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
6.1
32
109
ZX120
NOMESCO Finland
Intravenous
2.0
6.1
73
382
J01FA10
ATC
azithromycin; systemic
1.5
6.1
246
1851
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
6.1
436
3731
C02EA02
ATC
NA
2.2
6.1
57
268
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
612
2258
10.95
175.49
5.0
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
359
786
7.94
174.42
2.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
133
270
5.79
64.37
1.5
1.3
—
—
—
0
0
(4035726)
159
548
3.42
37.35
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
672
5122
4.44
34.28
28.8
18.8
ml/min/173m2
64.1
68.7
6.49
583
4317
(3002385) Erythrocyte distribution width [Ratio]
604
4320
3.18
34.07
35.5
24.0
%
14.3
14.1
1.98
593
4218
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
717
5758
9.24
33.80
16.1
11.6
u/l
23.2
23.7
0.44
685
5481
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
702
5549
6.29
33.48
28.4
19.7
mg/l
29.8
29.2
0.14
605
4677
(3019550) Sodium [Moles/volume] in Serum or Plasma
722
5852
11.16
33.24
33.4
23.9
mmol/l
139.4
139.5
0.58
708
5675
(3023103) Potassium [Moles/volume] in Serum or Plasma
722
5861
11.08
32.96
34.2
24.1
mmol/l
4.0
4.0
0.96
707
5682
(3024731) MCV [Entitic volume]
724
5909
12.10
32.43
41.0
28.7
fl
93.0
92.1
4.71
714
5768
(3007461) Platelets [#/volume] in Blood
724
5909
12.10
32.43
41.1
28.8
e9/l
219.6
230.4
3.83
700
5722
(3035941) MCH [Entitic mass]
724
5910
12.09
32.40
40.9
28.7
pg
30.7
30.5
1.31
714
5767
(3026361) Erythrocytes [#/volume] in Blood
724
5910
12.09
32.40
41.2
28.8
e12/l
4.3
4.3
2.88
699
5698
(3000963) Hemoglobin [Mass/volume] in Blood
724
5911
12.08
32.37
41.4
29.0
g/l
129.4
131.6
2.85
714
5768
(3010813) Leukocytes [#/volume] in Blood
724
5912
12.07
32.34
41.2
28.8
e9/l
7.5
7.0
1.39
699
5695
(3021589) Normoblasts [#/volume] in Blood
414
2529
2.45
30.98
16.3
10.7
e9/l
0.0
0.0
0.34
348
2072
(42870588) Differential panel, method unspecified - Blood
356
2070
2.39
29.27
9.0
5.2
—
—
—
0
0
(3044889) 12 lead EKG panel
576
4189
2.70
28.14
5.6
4.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
446
2902
2.35
27.73
8.9
5.1
e9/l
0.0
0.0
0.46
371
2484
(3001604) Monocytes [#/volume] in Blood
445
2894
2.35
27.68
8.9
5.1
e9/l
0.7
0.6
0.64
371
2462
(3018095) Leukocytes [#/volume] in Urine
393
2430
2.32
27.46
6.1
4.1
e6/l
92.4
131.4
0.49
288
1861
(3019069) Monocytes/100 leukocytes in Blood
429
2753
2.33
27.44
10.0
5.7
%
9.2
9.1
0.29
396
2562
(3022096) Basophils/100 leukocytes in Blood
420
2678
2.32
27.19
9.9
5.4
%
0.6
0.6
0.55
389
2493
(3006504) Eosinophils/100 leukocytes in Blood
426
2741
2.31
26.87
9.8
5.4
%
2.6
2.8
1.20
395
2541
(3018418) pH of Serum or Plasma
347
2054
2.30
26.67
6.4
4.3
ph
7.4
7.4
0.41
70
401
(3013115) Eosinophils [#/volume] in Blood
451
2986
2.31
26.37
9.7
5.3
e9/l
0.2
0.2
1.68
379
2588
(3018010) Neutrophils/100 leukocytes in Blood
423
2729
2.29
26.30
9.1
5.5
%
60.1
59.7
0.22
392
2540
(3002030) Lymphocytes/100 leukocytes in Blood
430
2794
2.29
26.27
10.0
5.7
%
25.6
24.5
0.79
397
2579
(3019198) Lymphocytes [#/volume] in Blood
446
2949
2.29
26.02
9.0
5.3
e9/l
2.8
1.8
1.26
376
2565
(3013650) Neutrophils [#/volume] in Blood by Automated count
490
3378
2.34
25.76
13.3
8.2
e9/l
4.5
4.4
0.04
431
2937
(3002582) Erythrocytes [#/volume] in Urine
357
2175
2.24
25.17
5.5
3.6
e6/l
77.5
111.5
0.38
280
1757
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
216
1065
2.45
25.01
4.1
2.7
%
21.0
21.7
0.27
194
900
(3023368) Bacteria identified in Blood by Culture
369
2284
2.23
24.95
5.2
4.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
685
5592
4.08
24.94
24.4
19.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
670
5397
3.59
24.88
6.2
5.5
mmol/l
2.3
2.4
3.19
591
4791
(3024561) Albumin [Mass/volume] in Serum or Plasma
452
3040
2.25
24.82
7.1
4.9
g/l
33.7
34.1
0.53
422
2808
(3004789) Transferrin [Mass/volume] in Serum or Plasma
223
1119
2.42
24.81
4.0
2.6
g/l
2.2
2.2
0.32
205
1031
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
89
273
3.57
24.59
2.1
2.7
g/l
0.9
1.3
0.34
76
235
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
52
106
5.20
24.51
6.8
5.2
iu/ml
454.4
280.4
—
10
14
(3015377) Calcium [Moles/volume] in Serum or Plasma
366
2272
2.21
24.41
4.4
3.4
mmol/l
2.3
2.3
0.19
301
1947
(3020779) Urea [Moles/volume] in Serum or Plasma
165
724
2.65
24.35
10.9
6.7
mmol/l
12.7
11.7
0.76
157
681
(3030467) Casts [#/volume] in Urine by Automated count
331
1979
2.22
24.19
5.3
3.5
e6/l
0.4
0.6
0.98
255
1572
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
81
236
3.73
24.15
1.8
2.5
g/l
0.0
0.0
0.25
73
216
(3031040) Bacteria [#/volume] in Urine by Automated count
561
4176
2.43
23.53
6.4
5.2
e6/l
309.2
2684.2
—
9
89
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
458
3146
2.20
23.19
8.7
6.2
mmol/l
1.2
1.2
0.21
425
2812
(3022948) Iron [Moles/volume] in Serum or Plasma
231
1211
2.32
22.99
4.0
2.6
umol/l
11.2
11.7
0.53
215
1116
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
395
2567
2.16
22.99
5.3
3.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
489
3457
2.23
22.90
10.7
7.1
mmol/l
1.2
1.2
0.16
419
2878
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
605
4688
2.60
22.74
11.4
7.7
u/l
83.6
82.7
0.14
566
4380
(3009542) Hematocrit [Volume Fraction] of Blood
597
4602
2.55
22.61
32.3
21.7
%
38.8
37.6
2.71
398
2622
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
221
1147
2.32
22.44
4.4
3.3
e6/l
1.0
1.8
1.50
124
688
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
189
920
2.42
22.19
5.5
3.7
u/l
238.8
246.8
0.48
182
865
(3001122) Ferritin [Mass/volume] in Serum or Plasma
379
2447
2.13
22.17
4.1
2.9
ug/l
167.5
168.7
0.03
343
2198
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
628
4979
2.74
22.04
5.0
4.6
mu/l
2.1
2.1
0.06
555
4366
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
435
2970
2.13
21.83
2.4
2.2
pmol/l
90.0
91.5
0.27
240
1583
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
300
3.28
21.76
1.8
2.6
g/l
3.1
3.2
0.23
71
235
(36304419) Bacteria [Presence] in Urine
309
1860
2.14
21.56
5.2
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
558
4221
2.31
21.29
6.6
4.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
288
1701
2.14
20.99
5.0
3.0
umol/l
13838.4
9994.5
0.34
248
1426
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
329
3.13
20.94
1.8
2.5
g/l
7.2
7.4
0.78
74
238
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
329
3.13
20.94
1.8
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
644
5212
2.83
20.90
7.9
7.1
mmol/mol
41.3
41.7
0.50
584
4694
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
328
3.10
20.43
1.8
2.5
g/l
3.8
3.7
0.43
70
231
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
79
254
3.36
20.21
1.8
2.4
g/l
37.3
36.6
0.48
66
215
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
469
3349
2.10
20.20
7.9
6.2
umol/l
14.4
12.7
1.69
448
3169
(3013826) Glucose [Moles/volume] in Serum or Plasma
522
3890
2.16
19.96
6.1
5.2
mmol/l
6.9
7.0
0.16
500
3674
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
655
5390
2.89
19.75
5.9
5.3
mmol/l
6.2
6.2
0.37
562
4736
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
188
958
2.29
19.60
1.9
1.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
195
1016
2.25
19.23
10.9
5.5
mmol/l
1.0
1.0
0.36
185
922
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
72
227
3.41
18.98
1.7
2.6
g/l
0.0
0.0
0.00
65
207
(3020630) Protein [Mass/volume] in Serum or Plasma
150
702
2.43
18.94
2.4
2.7
g/l
64.2
65.5
1.23
135
631
(40758558) Short blood count panel - Blood
252
1460
2.10
18.93
10.5
6.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
309
3.06
18.85
1.7
2.6
g/l
9.8
10.6
0.89
74
261
(3032080) INR in Blood by Coagulation assay
442
3143
2.01
18.58
14.2
12.8
inr
1.4
1.4
0.21
130
859
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
314
1982
2.02
18.56
2.9
2.3
mg/l
3.2
3.2
0.05
274
1683
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
71
225
3.38
18.56
1.7
2.6
g/l
0.0
0.0
0.00
65
207
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
358
2370
1.99
18.44
2.6
2.2
nmol/l
85.4
78.8
3.57
314
2032
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
355
2350
1.98
18.22
2.5
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
218
1215
2.13
17.99
4.2
3.1
e6/l
2.3
1.1
0.52
120
749
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
183
953
2.22
17.93
2.0
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
192
1028
2.17
17.50
2.1
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
635
5235
2.51
17.43
5.5
4.8
mmol/l
4.1
4.2
2.39
562
4685
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
143
685
2.35
17.01
3.8
2.8
umol/l
10.4
10.0
0.07
129
611
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
233
1368
2.03
16.48
2.2
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
626
5170
2.38
16.38
5.4
4.8
mmol/l
1.4
1.4
0.44
544
4573
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
297
1900
1.94
16.38
3.3
3.4
ug/l
0.9
0.8
0.10
210
1384
(3045142) Bone marrow Pathology biopsy report
38
84
4.71
16.28
1.4
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
188
1025
2.12
16.21
3.9
2.4
%
1.8
1.8
0.09
165
908
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
610
4998
2.26
16.04
4.9
4.3
mmol/l
1.2
1.2
0.30
524
4384
(3044640) Blood type and Crossmatch panel - Blood
316
2076
1.91
15.99
3.6
2.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
538
4210
2.02
15.93
37.9
26.8
g/l
329.2
331.1
4.38
533
4164
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
237
1419
1.99
15.74
3.3
3.3
mmol/l
2.5
2.5
0.81
204
1238
(3004588) Protein electrophoresis panel - Serum or Plasma
126
590
2.37
15.70
2.5
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
257
1586
1.95
15.61
4.2
2.7
e6/l
2.7
4.1
3.20
227
1409
(3013707) Erythrocyte sedimentation rate by Westergren method
544
4298
2.01
15.34
5.8
4.2
mm/h
15.5
15.5
0.01
502
3896
(3021960) Folate [Moles/volume] in Serum or Plasma
290
1883
1.89
14.96
1.7
1.7
nmol/l
20.7
19.7
0.49
243
1594
(3021601) Nitrite [Presence] in Urine by Test strip
397
2853
1.85
14.76
6.4
5.8
estimate
0.0
0.0
0.00
85
574
(3000494) Fungus identified in Specimen by Culture
139
698
2.22
14.63
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
152
792
2.16
14.59
2.0
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
198
1139
2.01
14.57
4.1
3.1
mmol/l
0.8
0.8
0.80
183
1055
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
119
563
2.33
14.43
2.7
2.3
u/l
31.4
35.8
0.58
106
474
(3009261) Glucose [Presence] in Urine by Test strip
401
2908
1.83
14.31
4.6
4.3
estimate
0.0
0.0
0.00
85
564
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
510
3985
1.90
14.30
3.8
3.6
pmol/l
14.9
15.2
1.47
445
3480
(3000991) Gas panel - Venous blood
134
669
2.23
14.29
7.7
7.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
398
2881
1.83
14.27
4.5
4.3
estimate
0.0
0.0
0.00
82
582
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
98
430
2.47
14.03
1.9
1.8
g/l
1.3
1.5
1.27
83
377
(3002032) Base excess in Venous blood by calculation
149
782
2.13
13.99
4.7
3.8
mmol/l
1.5
2.0
0.82
121
613
(3021447) Carbon dioxide [Partial pressure] in Venous blood
149
788
2.12
13.70
4.7
3.8
kpa
5.7
5.8
0.45
143
762
(3005719) IgG [Mass/volume] in Serum or Plasma
94
410
2.48
13.62
4.3
2.7
g/l
10.1
10.8
0.58
84
368
(3021440) Promyelocytes/100 leukocytes in Blood
106
491
2.35
13.45
6.7
3.8
%
0.1
0.1
0.21
41
174
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
117
568
2.26
13.30
5.9
4.1
ng/l
131.9
107.4
0.69
98
487
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
244
1549
1.86
13.16
3.4
2.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
52
168
3.25
13.16
2.0
2.3
g/l
3.8
3.8
0.02
52
156
(3026782) Osmolality of Urine
240
1527
1.85
12.79
4.5
3.0
mosm/kgh2o
542.3
564.9
1.03
213
1300
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
422
2.41
12.78
1.7
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
131
684
2.11
12.37
6.3
6.7
mmol/l
1.3
1.5
1.14
123
653
(3014576) Chloride [Moles/volume] in Serum or Plasma
174
1007
1.95
12.35
7.6
6.7
mmol/l
104.6
104.3
0.21
169
978
(3017181) Myelocytes/100 leukocytes in Blood
108
525
2.24
12.20
6.7
3.7
%
0.7
0.9
0.24
42
190
(3025159) Blasts/100 leukocytes in Blood
98
460
2.30
12.02
6.9
3.8
%
0.4
0.2
0.18
34
148
(3024354) Oxygen [Partial pressure] in Venous blood
125
650
2.11
11.90
3.4
3.0
kpa
4.7
4.4
0.88
117
627
(3034860) Kappa light chains.free [Mass/volume] in Serum
71
291
2.59
11.69
3.5
3.4
mg/l
72.4
81.2
0.11
55
242
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
71
292
2.58
11.61
3.5
3.4
mg/l
36.6
89.9
0.71
55
247
(3009508) Creatinine [Moles/volume] in Urine
297
2069
1.73
11.33
4.2
3.2
mmol/l
6.5
7.3
4.17
247
1675
(3020682) Albumin/Creatinine [Ratio] in Urine
314
2224
1.72
11.26
5.4
4.0
mg/mmol
13.8
10.0
0.93
211
1459
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
504
2.19
11.03
1.8
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
351
2578
1.69
10.89
3.6
3.4
ng/l
2518.7
2080.5
0.80
318
2270
(3023520) Reticulocytes [#/volume] in Blood
137
761
1.98
10.84
3.7
2.6
e9/l
68.2
67.6
0.07
92
611
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
124
3.35
10.82
1.7
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
96
467
2.21
10.78
6.1
3.7
%
0.4
0.6
0.73
29
139
(3017143) Hepatitis C virus Ab [Presence] in Serum
88
413
2.28
10.77
1.8
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
48
167
3.00
10.74
2.3
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
86
3.84
10.68
1.7
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
104
526
2.14
10.59
2.0
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
222
1450
1.76
10.49
4.9
4.3
ng/l
256.8
241.2
0.06
210
1305
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
380
2869
1.67
10.46
5.3
4.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
294
2076
1.69
10.46
4.2
3.3
mg/l
82.2
317.2
2.31
200
1382
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
183
2.86
10.23
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
183
2.86
10.23
1.4
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
58
4.43
10.11
1.8
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
104
3.48
10.11
1.8
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
104
3.48
10.11
1.7
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
41
135
3.16
10.08
2.3
2.4
%
219.8
214.8
0.11
41
128
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
433
3406
1.66
9.96
6.0
5.8
ug/l
2.2
4.9
1.49
361
2999
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
29
5.98
9.63
1.9
2.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
303
2193
1.65
9.59
3.7
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
207
1361
1.72
9.40
3.7
4.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
71
328
2.29
9.01
2.9
2.4
u/ml
0.4
0.4
0.04
41
193
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
357
2721
1.60
8.97
4.7
5.0
%
22.1
21.8
0.13
158
1483
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
26
5.87
8.35
2.2
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
60
267
2.36
8.30
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
32
103
3.20
8.19
7.9
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
107
599
1.92
8.17
1.3
1.3
titre
409.6
445.2
0.14
25
131
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
187
1238
1.68
8.12
1.7
1.7
mg/l
1.5
1.6
0.14
154
995
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
44
171
2.67
8.07
1.9
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
37
131
2.92
8.07
2.1
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
149
2.78
7.96
1.4
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
50
211
2.47
7.77
3.9
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
393
3130
1.55
7.73
3.3
3.2
u/l
67.5
60.5
0.50
354
2820
(3028026) IgM [Mass/volume] in Serum or Plasma
68
329
2.17
7.73
2.5
1.7
g/l
0.9
1.6
1.61
53
299
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
86
455
2.01
7.72
1.7
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
107
3.08
7.70
1.5
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
138
852
1.76
7.68
2.0
1.4
g/l
2.6
2.9
0.43
79
481
(40768797) Stomach Pathology biopsy report
129
782
1.79
7.64
1.3
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
244
1753
1.59
7.55
3.8
3.0
u/l
42.8
34.6
0.48
230
1676
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
130
800
1.76
7.30
2.9
3.2
ng/l
298.1
257.7
0.33
120
739
(40760892) CBC W Ordered Manual Differential panel - Blood
168
1110
1.66
7.27
7.8
4.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
126
771
1.76
7.21
4.9
4.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
182
2.51
7.14
1.9
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
24
71
3.46
7.02
4.9
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
47
205
2.38
6.82
4.6
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
106
626
1.81
6.82
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
15
32
4.76
6.71
1.4
2.1
%
16.0
18.1
—
6
15
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
200
1405
1.58
6.69
1.7
1.6
mmol/l
1.2
1.2
0.80
155
1126
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
102
604
1.80
6.50
6.7
3.7
mmol/l
1.2
1.2
0.20
91
525
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
186
2.39
6.37
1.5
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
44
193
2.36
6.32
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
162
2.49
6.30
2.6
1.9
g/l
123.8
125.9
0.19
29
119
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
109
2.83
6.28
1.5
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
213
2.29
6.27
1.8
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
35
139
2.59
6.20
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
50
235
2.21
6.13
2.0
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
170
1173
1.58
6.07
40.7
32.9
inr
1.7
1.5
0.67
22
148
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
89
2.99
6.05
1.7
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
96
2.88
5.89
1.6
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
162
2.42
5.82
2.8
2.2
%
15.9
15.5
0.29
23
73
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
47
3.68
5.51
1.2
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
48
235
2.11
5.34
1.3
1.2
u/ml
153.7
209.8
0.40
43
212
(3019309) Folate [Moles/volume] in Red Blood Cells
227
1709
1.47
5.32
1.8
1.8
nmol/l
1212.3
1160.9
0.25
159
1297
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
268
2085
1.45
5.29
2.5
2.2
u/l
215.5
265.1
0.46
251
1941
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
103
652
1.67
5.17
2.3
2.2
g/l
0.2
0.2
0.12
94
596
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
65
3.13
5.10
1.4
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
35
154
2.34
5.03
3.0
2.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
92
569
1.70
5.03
1.7
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
27
105
2.63
5.02
1.7
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
44
214
2.12
4.99
4.2
3.2
mmol/l
23.4
24.9
1.43
39
176
(3000093) Morphology [Interpretation] in Blood Narrative
20
67
3.04
4.86
1.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
37
3.84
4.83
1.1
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
37
3.84
4.83
1.1
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
52
3.32
4.77
1.2
1.1
—
—
—
0
0
(44790047)
22
79
2.84
4.75
1.9
1.5
—
—
—
0
0
(44790048)
22
79
2.84
4.75
1.9
1.5
—
—
—
0
0
(44790049)
22
79
2.84
4.75
1.9
1.5
—
—
—
0
0
(44806118)
22
79
2.84
4.75
1.9
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
31
133
2.39
4.73
7.5
3.4
%
0.4
1.3
1.51
24
103
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
5
14.11
4.58
2.6
8.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
25
4.45
4.57
2.4
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
29
123
2.41
4.54
1.7
1.4
e6/l
48645.9
54579.9
0.07
14
75
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
131
907
1.54
4.53
1.2
1.2
u/ml
2.0
1.5
0.21
23
220
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
49
3.32
4.49
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
49
3.32
4.49
1.2
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
40
3.55
4.35
4.0
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
116
791
1.55
4.29
3.8
4.0
ug/l
9.2
28.1
1.06
86
666
(3003694) ABO and Rh group [Type] in Blood
180
1346
1.45
4.25
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
73
2.79
4.21
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
27
4.12
4.17
1.1
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
161
2.17
4.16
1.7
1.5
iu/ml
0.3
33.6
0.56
12
40
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
110
2.41
4.11
5.7
2.9
%
53.8
62.3
1.92
26
110
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
65
387
1.75
4.09
2.3
2.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
22
86
2.61
4.08
1.0
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
176
2.10
4.07
1.5
1.5
ug/g
283.5
258.1
0.37
22
106
(3048689) Calprotectin [Mass/mass] in Stool
73
450
1.69
4.06
2.4
2.1
ug/g
231.4
158.4
0.35
62
354
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
249
1987
1.38
4.03
3.2
2.5
u/l
65.5
56.4
0.72
236
1829
(3023199) Leukocytes [#/volume] in Pleural fluid
30
137
2.24
4.01
1.6
1.4
e6/l
1032.1
1523.2
0.56
17
100
(3012441) Differential panel - Pleural fluid
27
118
2.34
3.98
1.6
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
484
1.66
3.98
3.9
3.3
ml/min/173m2
50.2
55.0
0.54
47
218
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
301
1.82
3.91
3.1
3.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
29
132
2.25
3.91
1.8
2.2
%
64.6
59.8
0.49
29
132
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
105
715
1.55
3.91
1.2
1.2
iu/ml
53.3
43.1
0.25
23
218
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
50
280
1.84
3.86
3.1
3.4
u/ml
1261.9
14631.9
0.72
42
232
(21494814) CD8 cells/100 lymphocytes in Specimen
9
15
6.06
3.82
1.3
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
35
175
2.05
3.75
5.9
4.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
77
493
1.63
3.72
9.0
8.5
%
0.6
0.7
0.62
77
487
(40768806) Pleura Pathology biopsy report
27
122
2.26
3.71
1.4
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
12
6.72
3.68
1.4
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
40
3.29
3.64
2.1
2.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
31
150
2.11
3.62
1.6
1.6
g/l
29.4
30.9
0.27
26
134
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
335
2835
1.33
3.60
4.8
4.5
ng/l
47.1
59.3
0.48
273
2290
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
77
497
1.61
3.60
9.0
8.4
%
1.3
1.4
0.57
77
491
(1761868) Lipid panel - Serum or Plasma
180
1384
1.40
3.59
3.9
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
272
1.82
3.59
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
27
124
2.22
3.58
1.1
1.1
—
95.0
—
0
10
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
105
2.33
3.56
5.1
2.5
e9/l
4.2
5.1
1.26
24
105
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
99
2.37
3.53
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
17
5.35
3.52
2.2
1.1
—
—
—
0
0
(3010421) pH of Blood
41
224
1.88
3.44
5.6
4.8
ph
7.4
7.4
0.05
34
184
(3004451) EKG impression Narrative
14
48
2.95
3.31
1.4
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
35
187
1.91
3.15
5.4
5.1
mmol/l
2.0
2.7
0.94
24
128
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
39
3.11
3.10
1.1
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
8
7.55
3.06
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
128
954
1.41
3.03
6.6
6.7
mmol/l
0.0
1.2
2.50
107
725
(3036525) Urea [Moles/time] in 24 hour Urine
5
5
10.06
2.98
2.6
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
192
1533
1.34
2.97
5.3
4.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
50
307
1.67
2.88
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
165
1.92
2.85
1.1
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
130
2.04
2.84
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
78
538
1.50
2.76
7.3
4.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
92
2.21
2.69
4.5
3.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
74
508
1.51
2.69
3.9
3.2
g/l
118.3
125.4
1.92
74
496
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
25
3.63
2.58
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
164
1.86
2.57
1.1
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
11
5.49
2.54
4.0
2.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
88
2.19
2.53
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
82
2.22
2.49
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
56
369
1.56
2.46
1.9
1.8
ug/l
1.3
3.4
0.80
49
308
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
45
2.69
2.46
3.8
4.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
51
2.58
2.45
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
167
1.83
2.44
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
379
1.55
2.41
3.3
2.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
15
64
2.37
2.40
4.1
2.3
ml
981.9
627.8
—
10
37
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
77
2.24
2.39
1.2
1.1
u/ml
245.2
344.2
0.82
11
37
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
69
481
1.48
2.35
5.0
3.9
mmol/l
1.8
2.1
0.27
42
348
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
9
28
3.24
2.31
10.6
3.5
u/l
227.6
212.4
—
9
28
(4034850)
7
184
0.37
2.31
11.0
14.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
72
2.25
2.29
1.0
1.1
g/l
1.5
1.7
0.54
16
64
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
41
2.71
2.28
2.2
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
171
1.79
2.28
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
18
3.92
2.25
1.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
71
504
1.45
2.22
5.3
3.9
ph
7.4
7.4
0.27
18
50
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
66
463
1.47
2.19
1.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
33
197
1.71
2.16
1.0
1.1
iu/ml
201.4
137.9
0.21
11
66
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
671
1.39
2.15
1.1
1.2
u/ml
30.8
14.3
0.57
27
223
(3022806) Fractional oxyhemoglobin in Capillary blood
21
109
1.95
2.12
1.6
2.0
%
85.6
88.6
0.36
21
109
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
71
510
1.43
2.09
5.3
3.9
kpa
5.0
5.2
0.70
62
467
(3042733) HLA Ab [Presence] in Serum
5
10
5.03
2.07
5.2
7.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
186
1.70
2.00
1.2
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
21
3.35
1.97
5.4
2.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
16
3.77
1.94
1.8
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
59
421
1.44
1.82
5.1
3.1
e6/l
0.4
0.3
0.12
59
416
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
96
744
1.33
1.82
2.4
2.8
ug/l
6.3
6.5
0.04
85
642
(21494890) Protein electrophoresis panel - 24 hour Urine
17
87
1.98
1.81
1.8
2.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
23
3.06
1.80
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
23
3.06
1.80
1.7
1.8
g/l
0.9
0.9
—
7
23
(3023410) Appearance of Cerebral spinal fluid
10
41
2.46
1.76
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
193
1643
1.24
1.74
5.4
4.6
estimate
0.0
0.0
0.00
75
536
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
42
2.40
1.68
10.6
3.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
97
1.88
1.67
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
371
1.43
1.63
1.3
1.6
%
1.7
1.8
0.13
40
289
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
91
1.89
1.61
10.8
3.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
63
2.08
1.60
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
20
114
1.78
1.58
3.1
2.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
40
275
1.48
1.52
2.9
2.6
g/l
0.4
0.3
0.46
20
104
(3014891) Appearance of Pleural fluid
6
21
2.87
1.51
1.7
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
21
2.87
1.51
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.87
1.51
1.0
1.0
—
—
—
0
0
(3013512) EKG study
235
2068
1.20
1.50
5.9
4.7
—
—
—
0
0
(3000012) Reticulocyte production index
10
45
2.24
1.47
1.2
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
80
1.89
1.45
1.5
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
81
1.87
1.41
1.4
2.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
67
1.96
1.39
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
104
1.75
1.38
1.3
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
41
2.21
1.37
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
112
1.71
1.36
3.5
2.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
17
2.95
1.36
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
283
1.44
1.34
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
42
2.16
1.34
1.4
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
242
1.47
1.32
1.1
1.3
—
70.5
—
0
13
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
249
2225
1.18
1.32
5.5
4.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
34
2.37
1.29
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
55
2.02
1.28
1.4
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
107
1.70
1.26
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
39
279
1.42
1.25
2.0
2.5
—
16.6
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
25
2.41
1.24
1.2
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
36
2.24
1.24
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
36
2.24
1.24
2.0
2.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
19
2.64
1.21
3.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
55
420
1.33
1.20
9.7
9.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
38
2.12
1.18
1.4
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
87
1.74
1.15
5.9
3.0
%
52.4
57.8
—
8
58
(4062490)
8
39
2.06
1.15
1.1
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
30
2.35
1.12
1.0
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
73
1.79
1.11
1.5
1.4
u/l
14.3
13.3
0.20
13
67
(3002523) Influenza virus A Ag [Presence] in Specimen
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
41
1.96
1.09
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
17
105
1.63
1.07
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
306
1.36
1.06
2.2
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
238
1.40
1.04
2.9
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
335
1.33
1.01
2.6
1.9
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
11
61
1.82
0.99
1.1
1.2
mu/l
37.0
42.1
—
6
53
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
157
1.48
0.97
1.5
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
51
1.77
0.94
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
37
1.90
0.94
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
37
1.90
0.94
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
142
1.49
0.93
1.4
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
9
52
1.74
0.92
1.1
1.1
mmol/l
40.8
33.9
—
9
46
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
78
1.68
0.92
1.2
1.2
—
34.7
—
0
7
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
86
1.64
0.91
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
479
1.25
0.86
2.1
2.2
nmol/l
12.0
11.5
0.14
51
401
(4010399)
54
435
1.26
0.85
1.5
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
65
1.70
0.82
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
122
1.49
0.80
1.3
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
33
1.82
0.79
3.2
3.4
nmol/l
461.7
119.4
—
6
33
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
82
1.60
0.78
2.8
2.8
—
—
—
0
0
(3000492) Spirometry study
53
432
1.24
0.77
2.2
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
69
579
1.21
0.76
3.1
4.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
53
1.71
0.75
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
158
1.40
0.75
1.8
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
67
792
0.83
0.74
5.4
5.0
%
33.9
32.8
0.37
42
510
(3023383) Lactate [Moles/volume] in Pleural fluid
7
38
1.85
0.73
1.1
1.4
mmol/l
1.8
3.1
—
7
32
(3044242) Glucose [Moles/volume] in Arterial blood
9
57
1.59
0.71
1.4
2.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
59
1.53
0.68
1.8
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
94
1.50
0.67
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
43
1.63
0.67
1.1
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
70
1.58
0.65
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
22
163
1.36
0.65
1.6
1.7
e6/l
11021.8
17035.1
0.57
14
115
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
29
1.73
0.64
1.0
1.8
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
49
1.64
0.62
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
67
575
1.18
0.61
4.1
3.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
22
0.00
0.59
0.0
1.2
—
15.9
—
0
12
(3035880) pH of Pleural fluid
10
64
1.57
0.58
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
55
1.46
0.56
1.8
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
55
1.46
0.56
1.1
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.8
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
187
1.29
0.53
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
38
317
1.21
0.49
4.6
4.4
—
—
—
0
0
(4281824)
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
47
1.49
0.47
1.6
3.2
—
—
—
0
0
(3039000) Anion gap in Blood
14
187
0.74
0.46
3.9
5.6
mmol/l
11.3
11.3
0.03
14
166
(3018572) Chloride [Moles/volume] in Blood
14
187
0.74
0.46
3.9
5.6
mmol/l
104.6
105.3
0.17
14
166
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
293
1.20
0.45
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
104
1.35
0.43
1.4
1.8
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
32
1.57
0.42
1.8
1.5
%
37.4
25.5
—
5
27
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
16
0.00
0.41
0.0
1.8
—
3.2
—
0
9
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.4
1.0
mmol/l
1.8
2.1
—
5
34
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
60
1.34
0.40
1.0
1.3
u/ml
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
36
1.39
0.38
1.6
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
67
1.35
0.38
3.7
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
49
431
1.15
0.37
5.8
3.4
mmol/l
24.6
25.0
0.28
49
416
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
3.7
1.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
134
1.27
0.37
1.2
1.3
mmol/l
56.6
61.4
0.23
17
110
(4306422)
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
108
1.30
0.35
1.4
1.8
nmol/l
60.6
47.4
0.75
14
98
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
173
1634
1.08
0.35
1.7
1.8
pmol/l
484.8
8804038.0
0.80
129
1329
(4094501)
9
126
0.71
0.35
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
7
52
1.35
0.31
1.1
1.2
—
6.4
—
0
17
(3001019) Free T4 and TSH panel - Serum or Plasma
7
54
1.30
0.30
1.7
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
7
55
1.28
0.30
1.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
103
1.27
0.28
1.5
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
63
1.27
0.28
2.3
1.9
mu/l
427.4
283.3
—
8
58
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
76
820
0.92
0.27
10.3
9.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
67
1.20
0.26
1.6
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
141
1.21
0.26
4.3
2.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
198
1.17
0.25
5.4
2.4
ug/min
110.0
83.0
0.24
15
115
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
142
1.20
0.25
1.9
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
87
1.27
0.24
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
143
1.19
0.23
1.7
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
3.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
3.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
3.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
3.2
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
5.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
123
0.81
0.20
1.3
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.0
—
10.5
—
0
6
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
49
1.23
0.20
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
41
376
1.10
0.19
6.7
4.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
44
405
1.09
0.19
6.5
4.0
%
45.4
46.2
0.07
44
399
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
63
1.11
0.17
1.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
437
1.08
0.17
3.9
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
120
1.17
0.16
1.6
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
235
1.11
0.16
2.5
3.4
nmol/l
0.7
0.8
1.44
21
183
(3017732) Neutrophils [#/volume] in Blood
40
371
1.08
0.15
3.0
3.4
e9/l
3.8
4.1
0.22
21
257
(3005570) Glucose [Moles/volume] in Urine
9
79
1.14
0.15
1.6
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
83
1.09
0.14
1.0
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
38
354
1.08
0.13
3.6
4.5
%
0.9
0.9
0.11
38
330
(3000330) Specific gravity of Urine by Test strip
42
393
1.07
0.13
6.6
4.3
—
—
—
0
0
(3019225) pH of Specimen
68
712
0.95
0.12
7.1
4.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
33
309
1.07
0.10
3.8
3.6
mmol/l
1.8
1.4
0.52
33
302
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
60
0.83
0.08
1.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
60
0.83
0.08
1.8
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
62
0.81
0.08
1.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
65
1.08
0.08
1.0
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
125
1277
0.97
0.07
4.4
4.9
kg/l
1.0
1.0
0.04
20
192
(3039443) Prostate specific Ag panel - Serum or Plasma
11
98
1.12
0.07
1.5
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
74
1.08
0.07
2.1
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
1.6
1.3
nmol/l
0.7
0.6
—
8
68
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
75
1.07
0.07
1.1
1.1
—
—
—
0
0
(4146454)
7
85
0.82
0.07
2.9
2.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
91
0.88
0.07
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
119
1.09
0.06
1.1
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
131
0.91
0.05
5.3
2.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
130
1.08
0.04
1.7
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
249
0.96
0.02
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
26
252
1.03
0.02
5.7
5.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
96
1.04
0.00
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
226
1.02
0.00
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
406
1.01
0.00
1.3
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
68
0.88
0.00
1.8
1.3
nmol/l
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
49
1.02
0.00
1.0
1.1
nmol/l
0.7
1.5
—
5
43
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
82
0.98
0.00
2.3
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
94
0.96
0.00
1.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
14.2
—
0
6
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
0.8
—
0
6
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
3.7
—
13.7
—
0
7
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
15.8
—
130.4
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
83
0.96
0.00
2.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
82
0.98
0.00
2.3
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
84
0.95
0.00
2.3
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
0.1
—
0
9
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
0.9
—
0
7
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
80
1.00
0.00
2.3
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
83
0.96
0.00
2.3
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_SCALPNECK – Carcinoma in situ of skin of scalp and neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).